- /
- Supported exchanges
- / F
- / GLH.F
Goldlion Holdings Limited (GLH F) stock market data APIs
Goldlion Holdings Limited Financial Data Overview
Goldlion Holdings Limited, an investment holding company, manufactures and distributes apparel in the People's Republic of China, Hong Kong SAR, and Singapore. It operates through three segments: Apparel in China Mainland and Hong Kong SAR, Apparel in Singapore, and Property Investment and Development. The company offers garments, leather goods, and accessories, as well as licenses its brand name; invests in, develops, and manages properties. It also engages in photovoltaic business. The company offers its products through distributors, self-operated retail shops, and factory outlets, as well as through e-commerce and custom ordering. Goldlion Holdings Limited was founded in 1968 and is based in Sha Tin, Hong Kong. Goldlion Holdings Limited is a subsidiary of Top Grade Healthcare Limited.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Goldlion Holdings Limited data using free add-ons & libraries
Get Goldlion Holdings Limited Fundamental Data
Goldlion Holdings Limited Fundamental data includes:
- Net Revenue: 1 103 M
- EBITDA: 80 079 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2018-06-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Goldlion Holdings Limited News
New
Dr David Stamler Appointed CEO
MELBOURNE, Australia, Jan. 7, 2021 /PRNewswire/ -- The Board of Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") is pleased to announce the appointment of Dr David Stamler ...
Dr David Stamler Appointed CEO
MELBOURNE, Australia, Jan. 7, 2021 /PRNewswire/ -- The Board of Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") is pleased to announce the appointment of Dr David Stamler ...
Alterity and UniQuest partner to reverse bacterial resistance to antibiotics
New commercial opportunity for PBT2 MELBOURNE, Australia, Dec. 21, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced it has been gr...
Alterity and UniQuest partner to reverse bacterial resistance to antibiotics
New commercial opportunity for PBT2 MELBOURNE, Australia, Dec. 21, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced it has been gr...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.